Using induced pluripotent stem cells as a tool for modelling carcinogenesis

doi:10.4252/wjsc.v7.i2.461

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9195)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

500

WORD

483

HTML

5346

Figures (1-2)

173

Tables (1-1)

427

Sum=6929

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1078

Download

1188

Sum=2266

Mar 26, 2015 (publication date) through Nov 7, 2024

Times Cited of This Article

Times Cited (35)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Stem Cells. Mar 26, 2015; 7(2): 461-469
Published online Mar 26, 2015. doi: 10.4252/wjsc.v7.i2.461

Table 1 Current induced pluripotent stem cells models of carcinogenesis

Malignancy	Study	Ref.
PDAC	Model of early PDAC and progression	Kim et al[73], 2013
CML	iPSCs from CML cell lines and primary patient samples	Carette et al[70], 2010
CML	iPSCs from CML cell lines and primary patient samples	Kumano et al[72], 2012
JML	Derived iPSCs from 2 JML patients	Gandre-Babbe et al[75], 2013
Gastrointestinal cancer	Generated iPSCs from multiple GI cancer cell lines	Miyoshi et al[69], 2010
Glioblastoma	iPSCs generated from glioblastoma-derived neural stem cells	Stricker et al[76], 2014; Stricker et al[77], 2013

iPSC: Induced pluripotent stem cells; PDAC: Pancreatic ductal adenocarcinoma; CML: Chronic myeloid leukaemia; JML: Juvenile myelomonocytic leukemia.

Citation: Curry EL, Moad M, Robson CN, Heer R. Using induced pluripotent stem cells as a tool for modelling carcinogenesis. World J Stem Cells 2015; 7(2): 461-469
URL: https://www.wjgnet.com/1948-0210/full/v7/i2/461.htm
DOI: https://dx.doi.org/10.4252/wjsc.v7.i2.461